Latest Updates
-
Telangana Statehood Day 2026: How India's 29th State Was Born From Decades of Defiance -
5th Bada Mangal 2026: Do These Simple Rituals To Seek Hanuman Ji's Blessings -
The Best Ever Banana Shake Recipe for Breakfast -
Horoscope for Today June 02, 2026 - Steady Progress, Clear Focus -
Cafe Style Pink Sauce Pasta Recipe: Your New Go-To Dinner -
7 Fabrics Your Wardrobe Needs This Summer For Style and Comfort -
Mumbai Famous Snack: Ragda Pattice Recipe -
"Japan Was Extra Fun This Year": Rashmika Mandanna Drops Sweet Glimpses With Vijay Deverakonda -
Andhra Style Paneer Biryani Recipe: Aromatic & Delicious -
Google Wants to Release 64 Million Bacteria-Infected Mosquitoes in the US: Here's Why
New Vaccine For Chlamydia (Genital Bacterial Infection) Passes The Safety Tests
According to a recent study report, a vaccine to protect people against the sexually transmitted infection, chlamydia, has passed the initial safety tests. It is the first of its kind to enter the human trials and more trials have to be done to check how well it works and what dose to give according to the study published in the journal, The Lancet Infectious Diseases [1] .
As per the study, national screening programmes and antibiotic treatment haven't worked to decrease the incidence rate of chlamydia, and till date no vaccines against it have been tested in clinical trials.

So, the aim of the study was to analyse the safety and immunogenicity, in humans, of a new chlamydia vaccine based on a recombinant protein subunit (CTH522) in a prime-boost immunisation schedule.
What Is Chlamydia?
According to the study, chlamydia is the most common sexually transmitted bacterial infection globally. It occurs when you have unprotected sex, even if there is no penetration. It spreads through semen or vaginal discharge, because the chlamydia bacteria live in semen and vaginal fluid.
If the bacterial infection isn't treated with antibiotics, it can cause serious complications and may even cause infertility. It is estimated that around 70 to 80 per cent of women suffer from chlamydia infection without symptoms. It is more common in women than men [2] .
Why A Vaccine Is Required For Chlamydia
Experts believe that vaccination could give long-lasting protection. In the trial, researchers compared two different formulations of the vaccine alongside a placebo jab in 35 women. Both the formulations are safe, but one of them is considered very effective.
The vaccine produces a type of immune response that could protect against chlamydia. But, the vaccine will be sent for further trials to test whether it is truly protective or not.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
- [1] Abraham, S., Juel, H. B., Bang, P., Cheeseman, H. M., Dohn, R. B., Cole, T., … Follmann, F. (2019). Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases.
- [2] Menon, S., Timms, P., Allan, J. A., Alexander, K., Rombauts, L., Horner, P., ... & Huston, W. M. (2015). Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women.Clinical microbiology reviews,28(4), 969-985.



Click it and Unblock the Notifications